PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

RecruitingOBSERVATIONAL
Enrollment

255

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

October 25, 2026

Study Completion Date

November 25, 2026

Conditions
Patent Ductus Arteriosus
Trial Locations (8)

26040

RECRUITING

Eskişehir Osmangazi University Hospital, Eskişehir

00146

NOT_YET_RECRUITING

Ospedale Pediatrico Bambin Gesù, Roma

Unknown

RECRUITING

Rawalpindi Institute of Cardiology, Rawalpindi

RECRUITING

Military Hospital, Tunis

RECRUITING

Aydın Adnan Menderes University Hospital, Aydin

RECRUITING

Çukurova University Hospital, Adana

RECRUITING

Dicle University Hospital, Diyarbakır

SW3 6NP

NOT_YET_RECRUITING

Royal Brompton & Harefield Hospitals, London

Sponsors
All Listed Sponsors
lead

Occlutech International AB

INDUSTRY